SPDR SERIES TRUST - S&P BIOTECH (XBI)

Historical Holders from Q1 2014 to Q3 2025

Symbol
XBI
Type / Class
Equity / S&P BIOTECH
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
124,142,718
Holdings value
$12,440,077,018
% of all portfolios
0.02%
Number of holders
647
Number of buys
237
Number of sells
-302
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 124,142,718 $12,440,077,018 +$858,934,869 $100.20 647
2025 Q2 117,272,814 $9,726,205,378 +$539,755,851 $82.93 617
2025 Q1 113,337,685 $9,191,574,908 +$456,960,963 $81.10 674
2024 Q4 108,924,755 $9,809,823,063 -$300,688,150 $90.06 729
2024 Q3 102,834,498 $10,159,737,396 +$652,372,762 $98.80 763
2024 Q2 98,866,861 $9,167,210,152 -$558,257,150 $92.71 753
2024 Q1 102,559,902 $9,730,962,931 +$1,468,652,699 $94.89 773
2023 Q4 84,306,665 $7,539,229,687 -$349,573,235 $89.29 742
2023 Q3 90,734,822 $6,629,175,325 +$306,052,362 $73.02 674
2023 Q2 86,009,843 $7,155,899,429 -$901,307,109 $83.20 704
2023 Q1 93,934,856 $7,160,468,506 +$183,962,514 $76.21 703
2022 Q4 92,607,412 $7,683,091,727 +$1,097,278,517 $83.00 734
2022 Q3 81,392,001 $6,461,190,127 -$142,863,815 $79.32 691
2022 Q2 84,808,968 $6,299,641,637 +$499,722,376 $74.27 684
2022 Q1 78,409,946 $7,048,358,412 +$613,537,361 $89.88 684
2021 Q4 67,337,299 $7,540,217,313 +$833,516,534 $111.96 688
2021 Q3 62,933,735 $7,912,765,727 -$446,273,061 $125.71 628
2021 Q2 66,775,493 $9,041,282,740 -$2,201,621,705 $135.40 653
2021 Q1 83,842,788 $11,371,792,438 -$1,202,147,433 $135.65 640
2020 Q4 85,648,877 $12,056,920,896 +$1,380,909,227 $140.78 642
2020 Q3 80,394,761 $8,962,587,757 -$25,560,323 $111.43 550
2020 Q2 83,807,625 $9,381,950,719 -$1,103,772,057 $111.95 520
2020 Q1 95,230,658 $7,372,384,721 +$1,588,421,424 $77.44 439
2019 Q4 66,225,002 $6,293,311,475 +$140,285,609 $95.11 470
2019 Q3 71,344,848 $5,443,126,189 +$152,715,865 $76.25 401
2019 Q2 66,459,439 $5,822,066,803 -$555,668,077 $87.71 422
2019 Q1 69,796,194 $6,319,037,242 +$552,093,388 $90.54 441
2018 Q4 60,582,473 $4,347,765,110 +$28,865,882 $71.75 422
2018 Q3 59,564,593 $5,707,577,717 -$130,898,195 $95.87 431
2018 Q2 60,464,478 $5,753,465,507 +$168,919,368 $95.19 428
2018 Q1 58,413,799 $5,125,122,298 +$1,134,798,005 $87.73 410
2017 Q4 45,744,125 $3,883,354,548 +$135,883,173 $84.87 396
2017 Q3 43,586,046 $3,771,528,836 -$268,277,033 $86.57 350
2017 Q2 46,611,235 $3,597,430,281 +$167,666,485 $77.18 313
2017 Q1 44,582,122 $3,090,994,782 +$589,775,116 $69.34 293
2016 Q4 36,596,491 $2,167,924,581 -$634,251,956 $59.19 275
2016 Q3 46,993,375 $3,114,104,096 +$342,475,890 $66.29 226
2016 Q2 42,802,426 $2,315,662,737 -$119,547,543 $54.08 201
2016 Q1 44,401,036 $2,294,153,280 +$45,889,608 $51.66 189
2015 Q4 43,460,778 $3,048,389,350 -$589,465,720 $70.20 196
2015 Q3 52,237,407 $3,252,514,720 +$2,245,643,754 $62.25 194
2015 Q2 15,680,794 $3,954,162,331 +$865,792,932 $252.24 191
2015 Q1 12,250,632 $2,761,923,747 +$193,679,439 $225.50 178
2014 Q4 11,583,784 $2,160,286,255 +$133,955,346 $186.47 144
2014 Q3 10,777,933 $1,680,658,051 +$65,546,789 $155.97 128
2014 Q2 10,369,766 $1,596,613,069 -$148,177,705 $153.99 121
2014 Q1 11,363,570 $1,619,000,068 +$284,673,346 $142.48 130